"Saving lives with nirmatrelvir/ritonavir one transplant patient at a time".

Transplant infectious disease : an official journal of the Transplantation Society(2023)

引用 0|浏览4
暂无评分
摘要
While administration of nirmatrelvir/ritonavir resulted in a significant increase in tacrolimus concentration, this did not result in significant nephrotoxicity. Early oral antiviral treatment in SOT recipients is feasible with medication management, even with limited tacrolimus trough monitoring.
更多
查看译文
关键词
COVID-19,SARS-CoV-2,nirmatrelvir/ritonavir,solid organ transplantation,tacrolimus
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要